TP53 mutations, which can significantly promote tumor growth, are consequentially associated with the development of PCa (Kaur et al., 2019), while SPOP is an important tumor-suppressor gene in PCa cells (Geng et al., 2017). Here, TP53 is linked to neoplasm.